A case report of greater saphenous vein thrombosis in a patient with coronavirus (COVID-19) infection

• Published in: Tropical Diseases, Travel Medicine and Vaccines
• Main Authors: Negin Hesam-Shariati, Poya Fatehi, Fardin Fathi, Morteza Abouzaripour, Mohammad Bakhtiar Hesam Shariati
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2021
• Subjects: Superficial vein thrombosis; Coronavirus; COVID-19; Ultrasonography; Case report; Arctic medicine. Tropical medicine; RC955-962; Arctic
• Online Access: https://doi.org/10.1186/s40794-021-00131-9; https://doaj.org/article/2ecbe160507b475aa9bfad8b0c8dc3dc

Abstract In December 2019, the World Health Organization (WHO) announced a series of pneumonia cases caused by an unknown origin, discovered in Wuhan, China. A dangerous virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a disease named acute respiratory syndrome, which was later popularly called coronavirus infection (COVID-19). Patients with acute COVID-19 are at high risk of thrombosis in various blood vessels due to hypercoagulability, blood stasis, and endothelial damage. In this study, we present a case report of a patient with COVID-19, who was hospitalized in one of the hospitals in Sanandaj, Iran. There were symptoms of fever, chills, muscle aches, cough, and tachycardia. Laboratory tests showed high levels of CRP, ESR, Ferritin CLIA, LDH and D-Dimer in this patient. Doppler ultrasound of the patient also revealed an abnormal finding, thrombosis in the right greater saphenous vein. This suggests that COVID-19 may lead to other negative effects through damage to blood vessels.